Iovance Biotherapeutics (IOVA) Earnings Date & Reports

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune systemâ€™s ability to recognize and destroy diverse cancer cells using therapies personalized for each patient... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

IOVA is expected to report earnings to fall 38.33% to -22 cents per share on August 07

Iovance Biotherapeutics IOVA Stock Earnings Reports

Q2'25

Est.

$-0.22

Q1'25

Missed

by $0.12

Q4'24

Beat

by $0.01

Q3'24

Beat

by $0.02

Q2'24

Beat

by $0.01

The last earnings report on May 08 showed earnings per share of -36 cents, missing the estimate of -23 cents. With 6.38M shares outstanding, the current market capitalization sits at 597.74M.

View a ticker or compare two or three

Compare

IOVA